Clinical Trial Update: Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant chemotherapy with camrelizumab for locally advanced esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Fudan University | Conditions: PFS | Phase 2 | Status: UNKNOWN